Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: LENSAR Inc., 3 years.
LENSAR Inc.
Director
HCW Biologics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | LENSAR Inc. | Grant or award | +17,421 | — | — |
| May 23, 2025 | LENSAR Inc. | Grant or award | +7,374 | — | — |
| May 16, 2025 | HCW Biologics Inc. | Open-market purchase | +1,342 | $7.45 | $9,998 |
| May 8, 2025 | HCW Biologics Inc. | Open-market purchase | +2,308 | $26.00 | $60,008 |
| Sep 3, 2024 | LENSAR Inc. | Open-market purchase | +685 | $4.50 | $3,083 |
| Aug 28, 2024 | LENSAR Inc. | Open-market purchase | +1,000 | $4.45 | $4,450 |
| Aug 27, 2024 | LENSAR Inc. | Open-market purchase | +500 | $4.50 | $2,250 |
| Aug 26, 2024 | LENSAR Inc. | Open-market purchase | +802 | $4.58 | $3,673 |
| Aug 22, 2024 | LENSAR Inc. | Open-market purchase | +2 | $4.30 | $9 |
| Aug 21, 2024 | LENSAR Inc. | Open-market purchase | +500 | $4.35 | $2,175 |
| Aug 20, 2024 | LENSAR Inc. | Open-market purchase | +500 | $4.20 | $2,100 |
| Aug 16, 2024 | LENSAR Inc. | Open-market purchase | +6 | $4.03 | $24 |
| Aug 14, 2024 | LENSAR Inc. | Open-market purchase | +1,000 | $4.20 | $4,200 |
| Aug 12, 2024 | LENSAR Inc. | Open-market purchase | +500 | $4.03 | $2,015 |
| May 7, 2024 | LENSAR Inc. | Grant or award | +22,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.